Saved in:
| Main Author: | Marzelino, Alfa |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2026
|
| Online Access: | https://doi.org/10.5281/zenodo.18626691 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status
by: Vitor Sousa
Published: (2015)
by: Vitor Sousa
Published: (2015)
Robust Multicenter CT Radiogenomics for Dual EGFR and KRAS Prediction in Lung Cancer with Stability-Aware Modeling and SHAP Interpretation
by: Mehrnia, Somayeh Sadat, et al.
Published: (2026)
by: Mehrnia, Somayeh Sadat, et al.
Published: (2026)
Correction to “Trametinib Overcomes KRAS ‐ G12V –Induced Osimertinib Resistance in a Leptomeningeal Carcinomatosis Model of EGFR ‐Mutant Lung Cancer”
Published: (2025)
Published: (2025)
Targeting KRAS in Cancer Therapy: Beyond Inhibitors
by: Chunhui Chen, et al.
Published: (2025)
by: Chunhui Chen, et al.
Published: (2025)
Long Short‐Term Memory‐Based Prediction of Indonesian Composite Stock Index Returns for Early Identification of Market Crises
by: Bagus Sartono, et al.
Published: (2025)
by: Bagus Sartono, et al.
Published: (2025)
Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment
by: Burak Kuzu, et al.
Published: (2025)
by: Burak Kuzu, et al.
Published: (2025)
Targeting KRAS in gynecological malignancies
by: Yuanyuan Peng, et al.
Published: (2024)
by: Yuanyuan Peng, et al.
Published: (2024)
Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer
by: Zhen Chen, et al.
Published: (2024)
by: Zhen Chen, et al.
Published: (2024)
A nova parceria para o desenvolvimento da África
by: Alfa Oumar Diallo
Published: (2008)
by: Alfa Oumar Diallo
Published: (2008)
RENASCIMENTO AFRICANO E DESENVOLVIMENTO
by: Alfa Oumar Diallo
Published: (2011)
by: Alfa Oumar Diallo
Published: (2011)
Comparación de tres pruebas diagnósticas para el aborto por rinotraqueítis infecciosa bovina en hatos lecheros
by: Alfa Bracho Cárdenas
Published: (2006)
by: Alfa Bracho Cárdenas
Published: (2006)
Carta de retratação
by: Alfa Oumar Diallo
Published: (2020)
by: Alfa Oumar Diallo
Published: (2020)
Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR ‐Mutated Advanced Nonsmall‐Cell Lung Cancer
by: Chia‐Yu Kuo, et al.
Published: (2025)
by: Chia‐Yu Kuo, et al.
Published: (2025)
Integrating Pharmacokinetics and Pharmacodynamics Modeling with Quantum Regression for Predicting Herbal Compound Toxicity
by: Roosan, Don, et al.
Published: (2025)
by: Roosan, Don, et al.
Published: (2025)
Open Science and Artificial Intelligence for supporting the sustainability of the SRC Network: The espSRC case
by: Garrido, J., et al.
Published: (2025)
by: Garrido, J., et al.
Published: (2025)
Phytochemical Analysis and Anticancer Activity of in Colorectal Cancer: An Integrated Transcriptomic and Bioinformatic Study.
by: Li, Long-Zhu, et al.
Published: (2026)
by: Li, Long-Zhu, et al.
Published: (2026)
Association of 3'UTR variations of EGFR and KRAS oncogenes with clinical parameters in lung cancer tumours
by: Ozkan Bagci
Published: (2024)
by: Ozkan Bagci
Published: (2024)
Identification of Key Targets of Herbal Compounds for Liver Fibrosis Using Network Pharmacology Combined With Transcriptomics
by: Chen Chen, et al.
Published: (2026)
by: Chen Chen, et al.
Published: (2026)
Taichunamide‐A Inhibits Stomach Cancer Growth Through AKT/MAPK Pathway Suppression and EGFR Inhibitor Synergy
by: Lian‐cheng Xu, et al.
Published: (2025)
by: Lian‐cheng Xu, et al.
Published: (2025)
Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1
by: Yilin Hong, et al.
Published: (2024)
by: Yilin Hong, et al.
Published: (2024)
Highly Specific Cytokine Receptor‐Targeting Chimeras for Targeted Membrane Protein Degradation and Sensitization of Osimertinib in EGFR‐Mutated Non‐Small‐Cell Lung Cancer
by: Jiawei Wu, et al.
Published: (2025)
by: Jiawei Wu, et al.
Published: (2025)
Análise do impacto de choques na taxa de juros Selic e do IPI sobre produção industrial
by: Alfa Iaia Sidico Samate
Published: (2019)
by: Alfa Iaia Sidico Samate
Published: (2019)
Targeting mutated KRAS in the first‐line therapy
by: Hideaki Ijichi
Published: (2024)
by: Hideaki Ijichi
Published: (2024)
Differential Response and Resistance to KRAS‐Targeted Therapy
by: Zhaojin Liu, et al.
Published: (2025)
by: Zhaojin Liu, et al.
Published: (2025)
Clinical Relevance of EGFR in Breast Cancer: Precision Targeting for Better Outcomes
by: Badhe, Pravin
Published: (2025)
by: Badhe, Pravin
Published: (2025)
Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS‐mutant Nonsmall Cell Lung Cancer
by: Nai‐jie Fu, et al.
Published: (2025)
by: Nai‐jie Fu, et al.
Published: (2025)
Integration of Bioinformatics and Experiments to Identify Mitochondrial Metabolism and Immune Infiltration Characterization in Lung Injury and Post‐Injury Lung Fibrosis
by: Cong‐cong Chen, et al.
Published: (2026)
by: Cong‐cong Chen, et al.
Published: (2026)
Lung Cancer: Targets and Therapy
Published: (2010)
Published: (2010)
Journal of Integrative Bioinformatics
Published: (2018)
Published: (2018)
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation
by: Chang Dong Yeo, et al.
Published: (2025)
by: Chang Dong Yeo, et al.
Published: (2025)
Comprehensive Bioinformatic Analysis of TONSL Expression in Pan‐Cancer
by: Ying Yang, et al.
Published: (2026)
by: Ying Yang, et al.
Published: (2026)
Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis
by: Yao Yu, et al.
Published: (2024)
by: Yao Yu, et al.
Published: (2024)
A Comprehensive Review on Potential In Silico Screened Herbal Bioactive Compounds and Host Targets in the Cardiovascular Disease Therapy
by: Elham Zarenezhad, et al.
Published: (2024)
by: Elham Zarenezhad, et al.
Published: (2024)
Imidazole–Oxadiazole‐Linked Sulfonyl‐1,2,3‐triazoles as Potential EGFR Inhibitors for Lung Cancer Treatment
by: Venkat Reddy Dodlapati, et al.
Published: (2025)
by: Venkat Reddy Dodlapati, et al.
Published: (2025)
EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer
by: Yuanzhou Zhang, et al.
Published: (2025)
by: Yuanzhou Zhang, et al.
Published: (2025)
Herbal Bioactive Targeting Prostate Cancer: A Network Pharmacology and Molecular Mechanism Perspective
by: Shubham Patil1, Ashok Bendgude2, Siddhi Shirahatti3, Ajit Patil4, Godfrey Mathews5
Published: (2026)
by: Shubham Patil1, Ashok Bendgude2, Siddhi Shirahatti3, Ajit Patil4, Godfrey Mathews5
Published: (2026)
A Logistics Book Hidden in a Linguistics Library Shelf: A Qualitative Examination of How Resource Constraints Manifest in Library Operations
by: Raphael Aryee, et al.
Published: (2025)
by: Raphael Aryee, et al.
Published: (2025)
An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect
by: Mohammad Amin Rajizadeh, et al.
Published: (2024)
by: Mohammad Amin Rajizadeh, et al.
Published: (2024)
First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis
by: Wei Du, et al.
Published: (2025)
by: Wei Du, et al.
Published: (2025)
The Mechanism of Scopolamine’s Effect on Migration Function of Lung Cancer Cells: A Network Pharmacology and Bioinformatics Perspective
by: Yang Xiao, et al.
Published: (2024)
by: Yang Xiao, et al.
Published: (2024)
Similar Items
-
Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status
by: Vitor Sousa
Published: (2015) -
Robust Multicenter CT Radiogenomics for Dual EGFR and KRAS Prediction in Lung Cancer with Stability-Aware Modeling and SHAP Interpretation
by: Mehrnia, Somayeh Sadat, et al.
Published: (2026) -
Correction to “Trametinib Overcomes KRAS ‐ G12V –Induced Osimertinib Resistance in a Leptomeningeal Carcinomatosis Model of EGFR ‐Mutant Lung Cancer”
Published: (2025) -
Targeting KRAS in Cancer Therapy: Beyond Inhibitors
by: Chunhui Chen, et al.
Published: (2025) -
Long Short‐Term Memory‐Based Prediction of Indonesian Composite Stock Index Returns for Early Identification of Market Crises
by: Bagus Sartono, et al.
Published: (2025)